ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 117 filers reported holding ENDOCYTE INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 100 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |